China’s State Food and Drug Administration and Brazil’s Anvisa healthcare regulatory agencies have met in Brasilia to further their collaboration in areas such as manufacturing inspections and information-sharing related to regulatory processes and standards1...
Scrip Regulatory Affairs
China's SFDA and Brazil's Anvisa meet in Brasilia to strengthen collaboration
22 June 2010
Bernard Murphy
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- China and Brazil aim to strengthen surveillance ties
- European industry bodies voice concern over CoE's anti-counterfeiting system
- More Indian drugs detained in EU as FTA talks progress ahead of summit
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
